AMLX Operating Cash Flow (Statement)
Amylyx Pharmaceuticals Inc · Operating Cash Flow (Statement)
AMLX Operating Cash Flow (Statement)
Latest reported-$31.42Mperiod ending
AMLX Quarterly Cash from Operations (-$8.89M → -$31.42M)
Quarterly operating cash flow (statement)
High-resolution chart · PNG
AMLX operating cash flow (statement) history
Quarterly · USD. Dates are reporting period ends; fiscal years can differ from calendar years.
| Period ending | Operating Cash Flow (Statement) (USD) |
|---|---|
| -31,424,000 | |
| -36,882,000 | |
| -27,903,000 | |
| -30,368,000 | |
| -25,248,000 | |
| -39,824,000 | |
| -59,008,000 | |
| -41,570,000 | |
| -66,580,000 | |
| -489,000 | |
| 13,551,000 | |
| -5,169,000 | |
| 8,609,000 | |
| -5,072,000 | |
| -49,697,000 | |
| -43,078,000 | |
| -46,462,000 | |
| -40,634,000 | |
| -28,244,000 | |
| -20,865,000 | |
| -13,047,000 | |
| -12,643,000 | |
| -8,888,000 |